Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Gilead Sciences
Related studies linked through entity extraction aliases.
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
- Status
- COMPLETED
- Phase
- PHASE3
GS-5885, GS-9451, Tegobuvir and Ribovirin in Treatment-Experienced Subjects With Chronic Genotype 1a Or 1b Hepatitis C Virus (HCV) Infection
- Status
- COMPLETED
- Phase
- PHASE2
Pharmacokinetics of Single-Dose Oral Ranolazine in Hemodialysis Patients
- Status
- COMPLETED
- Phase
- PHASE4
Safety Study of Regimens of Sofosbuvir, GS-0938, and Ribavirin in Patients With Chronic Hepatitis C Infection
- Status
- COMPLETED
- Phase
- PHASE2
GS-5885, GS-9451, Tegobuvir and Ribavirin (RBV) in Interferon Ineligible or Intolerant Subjects With Chronic Genotype 1a or 1b Hepatitis C Virus (HCV) Infection
- Status
- COMPLETED
- Phase
- PHASE2
Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GS-9669 in Subjects With Chronic Hepatitis C Virus Infection
- Status
- COMPLETED
- Phase
- PHASE1
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
- Status
- COMPLETED
- Phase
- PHASE4
Open Label Safety/Efficacy Study of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Gout Patients
- Status
- COMPLETED
- Phase
- PHASE2
Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower Airways
- Status
- COMPLETED
- Phase
- PHASE3
Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of Idelalisib in Relapsed or Refractory Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype
- Status
- TERMINATED
- Phase
- PHASE2
Aztreonam Lysine for Pseudomonas Infection Eradication Study
- Status
- COMPLETED
- Phase
- PHASE2
Registry to Monitor the Susceptibility to Aztreonam of Pseudomonas Aeruginosa Isolates From Cystic Fibrosis Patients
- Status
- COMPLETED
- Phase
- N/A
Oral Antivirals (GS-5885, Tegobuvir, and/or GS-9451) With Peginterferon Alfa 2a and Ribavirin in Treatment Experienced Subjects With Chronic Genotype 1 Hepatitis C Virus Infection
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Simtuzumab in Adults With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE2
Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Safety and Efficacy of GS-6624 (Formerly AB0024) in Patients With Idiopathic Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- PHASE1
GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus
- Status
- COMPLETED
- Phase
- PHASE2